AC Immune SA (ACIU)
2.98
+0.05
(+1.71%)
USD |
NASDAQ |
Apr 30, 11:13
AC Immune Shareholders Equity (Quarterly) : 56.65M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Novartis AG | 38.51B |
| EvoNext Holdings SA | -- |
| Kuros Biosciences Ltd. | -- |
| Basilea Pharmaceutica AG | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 194.70M |
| Total Liabilities (Quarterly) | 138.05M |
| Debt to Equity Ratio | 0.1012 |
| Current Ratio | 1.021 |
| Net Debt Paydown Yield | -0.13% |